-+ 0.00%
-+ 0.00%
-+ 0.00%

Amphastar Pharmaceuticals holds annual shareholder meeting

PUBT·06/03/2026 20:18:00
Listen to the news
Amphastar Pharmaceuticals holds annual shareholder meeting
  • Amphastar Pharmaceuticals held its annual shareholder meeting on May 26, 2026.
  • Shareholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders backed an annual frequency for future advisory votes on named executive officer compensation; the board set the vote to occur yearly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amphastar Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001297184-26-000038), on June 03, 2026, and is solely responsible for the information contained therein.